Patrick Yéni

13.2k citations
90 papers · 8.9k · 7 hit papers · h-index 32

Impact in

  • Virology top 0.1%
    • HIV Research and Treatment
  • Infectious Diseases top 0.05%
    • HIV/AIDS drug development and treatment
    • HIV/AIDS Research and Interventions

Papers in

  • Infectious Diseases 63
    • HIV/AIDS drug development and treatment 49
    • HIV/AIDS Research and Interventions 17
    • Antifungal resistance and susceptibility 5
    • Tuberculosis Research and Epidemiology 4
  • Virology 26
    • HIV Research and Treatment 25
Co-authors
Douglas D. Richman (10 shared papers)Scott M. Hammer (10 shared papers)Donna M. Jacobsen (10 shared papers)Melanie Ann Thompson (9 shared papers)Robert T. Schooley (10 shared papers)Paul A. Volberding (8 shared papers)Martin Hirsch (9 shared papers)Margaret A. Fischl (8 shared papers)
Journals
AIDS (12 papers)JAMA (7 papers)Antiviral Therapy (7 papers)Clinical Infectious Diseases (6 papers)Scandinavian Journal of Infectious Diseases (4 papers)
Partner nations
FranceUnited StatesUnited Kingdom

In The Last Decade

Patrick Yéni

88 papers receiving 8.4k citations

Patrick Yéni's Hit Papers

Antiretroviral Treatment of Adult HIV Infection 2010 · 630 citations
6300+9+18Years since publication250500750
What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

  1. 2010 JAMA
  2. 2008 JAMA
  3. 2006 JAMA
  4. 2004 JAMA
  5. 2002 JAMA
  6. 2000 JAMA
  7. 1998 JAMA

Peers

Patrick Yéni
Comparison fields: 5 of 134
  • Virology 3.6k
  • Infectious Diseases 6.0k
  • Emergency Medicine 1.3k
  • Hepatology 390
  • Epidemiology 1.6k
Replace Roy M. Gulick with:
Roy M. Gulick United States
Donna M. Jacobsen United States
David A. Cooper Australia
Judith Feinberg United States
Jack Fuhrer United States
Diane J. Aschman United States
Edwin DeJesus United States
Mark O. Loveless United States
Alexandra Calmy Switzerland
Pedro Enrique Cahn Argentina
Patrick Yéni relative to Roy M. Gulick United States Roy M. Gulick's profile →
Citations per field
00.5×1.5×
Roy M. Gulick · 1×
Citations per year

Countries citing papers authored by Patrick Yéni

Since Specialization
Citations

This map shows the geographic impact of Patrick Yéni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Yéni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Yéni more than expected).

Fields of papers citing papers by Patrick Yéni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Yéni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Yéni. The network helps show where Patrick Yéni may publish in the future.

Co-authors

The 25 scholars most cited alongside Patrick Yéni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Patrick Yéni Line = papers co-authored together Patrick Yéni links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Antiretroviral Therapy in Adults
JAMA ·Charles C. J. Carpenter, David A. Cooper, Margaret A. Fischl, José M. Gatell, Brian Gazzard, Scott M. Hammer, Martin Hirsch, Donna M. Jacobsen, David Allan Katzenstein, Joan Montaner, Douglas D. Richman, Michael S. Saag, Mauro Schechter, Robert T. Schooley, Melanie Ann Thompson, Stefano Vella, Patrick Yéni, Paul A. Volberding
Hit paper breakdown →		2000912
2
Antiretroviral Treatment of Adult HIV Infection
JAMA ·Scott M. Hammer, Joseph J. Eron, PETER C. REISS, Robert T. Schooley, Melanie Ann Thompson, Sharon Lynn Walmsley, Pedro Enrique Cahn, Margaret A. Fischl, José M. Gatell, Martin Hirsch, Donna M. Jacobsen, Joan Montaner, Douglas D. Richman, Patrick Yéni, Paul A. Volberding
Hit paper breakdown →		2008888
3
Antiretroviral Therapy for HIV Infection in 1998
JAMA ·Charles C. J. Carpenter, Margaret A. Fischl, Scott M. Hammer, Martin Hirsch, Donna M. Jacobsen, David Allan Katzenstein, Julio S. G. Montaner, Douglas D. Richman, Michael S. Saag, Robert T. Schooley, Melanie Ann Thompson, Stefano Vella, Patrick Yéni, Paul A. Volberding
Hit paper breakdown →		1998880
4
Treatment for Adult HIV Infection
JAMA ·Scott M. Hammer, Michael S. Saag, Mauro Schechter, Joan Montaner, Robert T. Schooley, Donna M. Jacobsen, Melanie Ann Thompson, Charles C. J. Carpenter, Margaret A. Fischl, Brian Gazzard, José M. Gatell, Martin Hirsch, David Allan Katzenstein, Douglas D. Richman, Stefano Vella, Patrick Yéni, Paul A. Volberding
Hit paper breakdown →		2006805
5
Antiretroviral Treatment of Adult HIV Infection
JAMA ·Melanie Ann Thompson, Judith A. Aberg, Pedro Enrique Cahn, Joan Montaner, Giuliano Rizzardini, Amalio Telenti, José M. Gatell, Huldrych Fritz Günthard, Scott M. Hammer, Martin Hirsch, Donna M. Jacobsen, PETER C. REISS, Douglas D. Richman, Paul A. Volberding, Patrick Yéni, Robert T. Schooley
Hit paper breakdown →		2010630
6
Treatment for Adult HIV Infection
JAMA ·Patrick Yéni, Scott M. Hammer, Martin Hirsch, Michael S. Saag, Mauro Schechter, Charles C. J. Carpenter, Margaret A. Fischl, José M. Gatell, Brian Gazzard, Donna M. Jacobsen, David Allan Katzenstein, Joan Montaner, Douglas D. Richman, Robert T. Schooley, Melanie Ann Thompson, Stefano Vella, Paul A. Volberding
Hit paper breakdown →		2004628
7
Antiretroviral Treatment for Adult HIV Infection in 2002
JAMA ·Patrick Yéni, Scott M. Hammer, Charles C. J. Carpenter, David A. Cooper, Margaret A. Fischl, José M. Gatell, Brian Gazzard, Martin Hirsch, Donna M. Jacobsen, David Allan Katzenstein, Julio S. G. Montaner, Douglas D. Richman, Michael S. Saag, Mauro Schechter, Robert T. Schooley, Melanie Ann Thompson, Stefano Vella, Paul A. Volberding
Hit paper breakdown →		2002603
8
Antiretroviral Drug Resistance Testing in Adult HIV‐1 Infection: 2008 Recommendations of an International AIDS Society–USA Panel
Clinical Infectious Diseases ·Martin S. Hirsch, Huldrych Fritz Günthard, Jonathan Schapiro, Françoise Brun‐Vézinet, Bonaventura Clotet, Scott M. Hammer, Victoria Anne Johnson, Daniel R. Kuritzkes, John W. Mellors, Deenan Pillay, Patrick Yéni, Donna M. Jacobsen, Douglas D. Richman
2008403
9
Prevalence of HIV-Related Pulmonary Arterial Hypertension in the Current Antiretroviral Therapy Era
American Journal of Respiratory and Critical Care Medicine ·O Sitbon, Caroline Lascoux‐Combe, Jean‐François Delfraissy, Patrick Yéni, François Raffi, Dominique de Zuttere, Virginie Gressin, Pierre Clerson, D. Séréni, Gérald Simonneau
2007343
10
The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial
The Lancet ·Joseph J. Eron, Patrick Yéni, Joseph Gathe, Vicente Estrada, Edwin DeJesus, Schlomo Staszewski, Philip Lackey, Christine Katlama, Benjamin Young, Linda Yau, Denise Sutherland‐Phillips, Paul G. Wannamaker, Cindy Vavro, Lisa G. Patel, Jane Yeo, Mark S. Shaefer
2006285
11
Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel.
PubMed ·Scott M. Hammer, Michael S. Saag, Mauro Schechter, Joan Montaner, Robert T. Schooley, Donna M. Jacobsen, Melanie Ann Thompson, Charles C. J. Carpenter, Margaret A. Fischl, Brian Gazzard, José M. Gatell, Martin Hirsch, David Allan Katzenstein, Douglas D. Richman, Stefano Vella, Patrick Yéni, Paul A. Volberding
2006268
12
Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial
The Lancet Infectious Diseases ·Jan van Lunzen, Franco Maggiolo, José Ramón Arribas, Aza Gasanovna Rakhmanova, Patrick Yéni, Benjamin Young, Jürgen Kurt Rockstroh, Steve Almond, Ivy H. Song, Cindy H Brothers, Sherene Min
2011246
13
A Randomized Trial of Three Maintenance Regimens Given after Three Months of Induction Therapy with Zidovudine, Lamivudine, and Indinavir in Previously Untreated HIV-1–Infected Patients
New England Journal of Medicine ·Gilles Pialoux, François Raffi, Françoise Brun‐Vézinet, Vincent Meiffrédy, Philippe Flandre, Jean‐Albert Gastaut, P. Dellamonica, Patrick Yéni, Jean‐François Delfraissy, Jean-Pierre Aboulker
1998186
14
Efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients: 24-week results of POWER 1
AIDS ·Christine Katlama, Roberto Esposito, José M. Gatell, Jean‐Christophe Goffard, Beatriz Gilda Jegerhorn Grinsztejn, Anton Louis Pozniak, Jürgen Kurt Rockstroh, Albrecht D. Stoehr, Norbert Vetter, Patrick Yéni, Wim Parys, Tony Vangeneugden
2007153
15
Increased risk of lipoatrophy under stavudine in HIV-1-infected patients
AIDS ·Véronique Joly, Philippe Flandre, Vincent Meiffrédy, Nicolas Leturque, Marine Harel, Jean-Pierre Aboulker, Patrick Yéni
2002149
16
Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults
AIDS ·Philippe Lesprit, G. Pédrono, Jean‐Michel Molina, Cécile Goujard, Pierre‐Marie Girard, Nathalie Sarrazin, Christine Katlama, Patrick Yéni, P Morineau, Jean‐François Delfraissy, Geneviève Chêne, Yves Lévy
2007107
17
Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials
The Lancet Infectious Diseases ·Joseph J. Eron, David A. Cooper, Roy T. Steigbigel, Bonaventura Clotet, José M. Gatell, Princy N. Kumar, Jürgen Kurt Rockstroh, Mauro Schechter, Martin Markowitz, Patrick Yéni, Mona Rafik Loutfy, Adriano Lazzarin, Jeffrey L. Lennox, Kim M. Strohmaier, Hong I. Wan, Richard J. O. Barnard, Bach-Yen Nguyen, Hedy Teppler
2013102
18
Update on HAART in HIV
Journal of Hepatology ·Patrick Yéni
200587
19
A dose-ranging study to evaluate the safety and efficacy of abacavir alone or in combination with zidovudine and lamivudine in antiretroviral treatment-naive subjects
AIDS ·Schlomo Staszewski, Christine Katlama, T. Harrer, Patrice Massip, Patrick Yéni, Amy G. Cutrell, Stephanie M. Tortell, Richard Paul Harrigan, Helen M. Steel, Randall Lanier, Gillian L. Pearce
199876
20
Diagnosis of Primary Tuberculosis in Children by Amplification and Detection of Mycobacterial DNA
American Review of Respiratory Disease ·(unknown), Catherine Weil Olivier, Denise Lecossier, Yves Boussougant, Patrick Yéni, Allan J. Hance
199371

About Patrick Yéni

Patrick Yéni is a scholar working on Infectious Diseases, Virology, Emergency Medicine, Epidemiology and Microbiology, having authored 90 papers that have together received 8.9k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (49 papers), HIV Research and Treatment (25 papers), HIV/AIDS Research and Interventions (17 papers), HIV-related health complications and treatments (12 papers), Pneumocystis jirovecii pneumonia detection and treatment (9 papers), Antifungal resistance and susceptibility (5 papers), Tuberculosis Research and Epidemiology (4 papers) and Fungal Infections and Studies (3 papers). The work is most often cited by research in Virology (3.6k citations), Infectious Diseases (6.0k citations), Emergency Medicine (1.3k citations), Hepatology (390 citations) and Epidemiology (1.6k citations). Patrick Yéni has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Douglas D. Richman, Scott M. Hammer, Donna M. Jacobsen, Melanie Ann Thompson, Robert T. Schooley, Paul A. Volberding, Martin Hirsch, Margaret A. Fischl, José M. Gatell and Joan Montaner. Their work appears in journals such as AIDS, JAMA, Antiviral Therapy, Clinical Infectious Diseases and Scandinavian Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roy M. GulickBreakdown of academic impact, for papers by Donna M. JacobsenBreakdown of academic impact, for papers by David A. CooperBreakdown of academic impact, for papers by Judith FeinbergBreakdown of academic impact, for papers by Jack FuhrerBreakdown of academic impact, for papers by Diane J. AschmanBreakdown of academic impact, for papers by Edwin DeJesusBreakdown of academic impact, for papers by Mark O. LovelessBreakdown of academic impact, for papers by Alexandra CalmyBreakdown of academic impact, for papers by Pedro Enrique Cahn